Abstract: The unique annual herbaceous Cannabis plant variety C. sativa ‘V1’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.

Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V3’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.

Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V2’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.

Abstract: The unique annual herbaceous Cannabis plant variety C. sativa ‘V1’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.

Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V3’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.

Abstract: The new cannabis plant variety C. sativa ‘V3’ is provided. ‘V3’ is intended for use as medicinal herb for sale in cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin (THCV).

Abstract: The new Cannabis plant variety ‘V1’ is provided. ‘V1’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin (THCV) to a greater amount by percent weight than tetrahydrocannabinol (THC) and production of the unique terpene, farnesene.

Abstract: The new cannabis plant variety ‘V2’ is provided. ‘V2’ is intended for use as medicinal herb for sale in cannabis dispensaries for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin and production of the unique terpene, farnesene.

Abstract: The unique annual herbaceous cannabis plant variety C. sativa ‘V2’ is provided. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin. The enhanced production of THCV inhibits the stimulation to eat normally associated with tetrahydrocannabinol.

Abstract: An apparatus for use with a fan coil cabinet occluded by a releasably secured baffle having intake and discharge vents communicating with the cabinet and containing a coil which water passes and a fan which forces air past the coil for conditioning, wherein the fan has an outlet and a coil. The apparatus comprises a housing with the fan and coil mounted thereto, and a support mounted to the cabinet wherein the housing slides for movement between a retracted position, within the cabinet, and an extended position, protruding from the cabinet. The housing has a port with the fan coupled thereto for sealed communication between the port and the outlet. The coil and the housing define a cavity with which the port communicates. The housing defines an aperture and a door releasably secured in occluding relation to the aperture to provide access to the cavity for maintenance of the coil.

Abstract: The new Cannabis plant variety C. sativa ‘V3’ is provided. ‘V3’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin (THCV).

Abstract: The new Cannabis plant variety ‘V2’ is provided. ‘V2’ is intended for use as medicinal herb for sale in Cannabis dispensaries for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding feature of increased production of tetrahydrocannabivarin.

Abstract: The new Cannabis plant variety ‘V1’ is provided. ‘V1’ is intended for use as medicinal herb for sale in Cannabis dispensaries and for use in the manufacture of medicinal and recreational products. The variety can be distinguished by its outstanding features of increased production of tetrahydrocannabivarin (THCV) to a greater amount by percent weight than tetrahydrocannabinol (THC).